Andreas Klosterman, Ph.D. (CSO) will give an update on selectION’s best-in-class ion channel antagonists and discuss the principles of the company’s systematical peptide design to obtain the most selective and specific ion channel blockers.
Site Search
Recent News
- Meet selectION, Inc. at the BIO-EUROPE SPRING Conference in Basel, Switzerland, on March 20th to March 22nd, 2023
- Meet selectION, Inc. at the Global Life Science Partnering & Investor Conference in La Jolla, CA, on February 28th to March 2nd, 2023
- Meet selectION, Inc. at the 41stAnnual J.P. Morgan Healthcare Conference in San Francisco, CA, on January 9th to 12th, 2023